Comparing Early Combination of Statin and Ezetimibe Versus Statin Alone for Lowering LDL Cholesterol in Adults After Recent Ischemic Stroke with Atherosclerosis
Led by Chang Gung Memorial Hospital · Updated on 2025-12-30
300
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of starting a combination of moderate-intensity statin plus ezetimibe versus moderate- or high-intensity statin alone in patients who recently had an ischemic stroke or transient ischemic attack TIA and have atherosclerosis. This randomized controlled trial aims to determine which treatment better lowers LDL cholesterol levels to below 70 mgdL, with participants recruited within 30 days after their stroke or TIA. The study is conducted across six medical institutions in Taiwan and sponsored by Chang Gung Memorial Hospital.
Participants will be randomly assigned to one of two groups the experimental group receiving a fixed-dose combination of statin and ezetimibe such as simvastatin 20mgezetimibe 10mg, atorvastatin 20mgezetimibe 10mg, rosuvastatin 10mgezetimibe 10mg, or ezetimibe added to moderate-intensity statins or the control group receiving moderate- or high-intensity statin monotherapy including atorvastatin 10-80 mgday, rosuvastatin 5-20 mgday, or pitavastatin 1-4 mgday. Treatment starts within 2 days after randomization.
During the study, participants will have their LDL cholesterol levels measured at 3 and 6 months after randomization to assess treatment effects. Researchers will monitor LDL-C levels to see if they reach below 70 mgdL, the primary outcome measured at 6 months. Patients will be screened by research assistants and attending physicians for eligibility, and the trial runs until July 2029, involving adults aged 20 to 100 years old who had recent ischemic stroke or TIA with LDL-C levels of 100 mgdL or higher and evidence of atherosclerosis.
CONDITIONS
Brief Title
Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
Research Team
M
Meng Lee, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Clinical diagnosis of ischemic stroke or transient ischemic attack (TIA)
Stroke or TIA symptoms and randomized within 30 days
Start assigned medication within 2 days of randomization
Aged 20 years or older
LDL cholesterol (LDL-C) level 100 mg/dL or higher after index ischemic stroke or TIA
Evidence of atherosclerosis
You will not qualify if you...
End stage renal disease
History of statin intolerance
History of ezetimibe intolerance
Alanine aminotransferase (ALT) level greater than 100 U/L
Regular use of statins before stroke
Use of ezetimibe before stroke
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - 6 months
Participants receive either a combination of moderate-intensity statin plus ezetimibe or statin monotherapy to lower LDL cholesterol levels.
Participants begin assigned medication within 2 days of randomization and are monitored throughout treatment.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Imaging Carotid Artery Plaques Using 18F FDG and 68Ga FAPI PETMR to Study Plaque Vulnerability and Stroke Risk
Evaluating Two Dosages of Bevifibatide Injection for Treating Acute Ischemic Stroke Without Large Vessel Blockage in Adults
Evaluating the Adaptive Tip Catheter for Mechanical Thrombectomy in Acute Ischemic Stroke Patients During Treatment
Vagus Nerve Stimulation with Mobility Training to Improve Walking After Chronic Ischemic Stroke
Phase 1 Study to Assess the Safety, Tolerability, and Body Processing of LWP779 in Healthy Adults Aged 18 to 65
Study of Acetyl-leucine for Improving Balance in Adults With Post-stroke Ataxia Following Ischemic Stroke
Study of Adenosine A2A Receptor Role in Neuroinflammation and Remote Ischemic Conditioning for Treating Post-Stroke Insomnia
Study of Intra-arterial Tenecteplase with Mechanical Thrombectomy for Treating Acute Ischemic Stroke in Adults
Study of Ischemic Stroke Patients on Oral Anticoagulants with Atrial Fibrillation or Cardioembolic Arrhythmias
Tracking Stroke Outcomes and Prevention Strategies Over Time
Evaluating Ambulatory Stroke Unit Care Compared to Inpatient Stroke Unit Treatment for Patients Aged 60 and Older with Acute Ischemic Stroke or Related Conditions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials.